REN Danfeng , YAN Taotao , LIU Jingfeng , YANG Nan , ZHU Li , YANG Yuan , CHEN Tianyan , ZHAO Yingren , HE Yingli
  • Department of Infectious Diseases of the First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710000, P.R.China;
HE Yingli, Email: heyingli2000@163.com
Chronic hepatitis B virus; Infected person; Antiviral therapy; Liver stiffness measurement
10.7507/1672-2531.202102009
Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables References Cited by

Objective Antiviral treatments could benefit chronic hepatitis B (CHB) patients with the regression or improvement of liver fibrosis. However, the degree of dynamic change of liver fibrosis for patients who had not received antiviral treatment remained to be studied. The current study aimed to observe the long-term variation of liver stiffness measurement (LSM), virological and biochemical response on patients without standard antiviral therapy.Methods A total of 220 patients who were diagnosed with chronic HBV infection, who had not reached the standard of antiviral therapy, and completed a follow-up date of over 2 years in the First Affiliated Hospital of Xi’an Jiaotong University from 2012 to 2018 were retrospectively enrolled. According to the changes of LSM in baseline and follow-up period, the patients were divided into regression group, non-progressive group, and progressive group. The virological and biochemical characteristics of each group were analyzed.Results Among the 220 patients, 153 patients (69.5%) had no progress in LSM degree. Alanine aminotransferase (ALT), HBV DNA, and HBsAg in a few patients increased or slightly decreased, while the vast majority remained in a relatively stable state. 89.5% (137/153) of the non-progressive patients were in grade F0. In addition, 58 patients showed spontaneous improvement with a decreasing rate of 0.460 kPa per year. Patients with ALT of 1-2 ULN had a statistically significant decrease in LSM improvement compared to patients with normal ALT. 82.8% of the LSM-improving patients showed baseline LSM of F1-F3. Only 9 patients showed LSM deterioration, however, which could not be explained by virus replication or necroinflammatory activity. Conclusions For patients unsatisfying standard antiviral therapy, most patients with baseline LSM of F0 grade fail to progress, and patients with baseline LSM of F1-F3 show a decrease during follow-up, LSM progression occurs in 4.1% of patients.

Citation： REN Danfeng, YAN Taotao, LIU Jingfeng, YANG Nan, ZHU Li, YANG Yuan, CHEN Tianyan, ZHAO Yingren, HE Yingli. Long-term dynamic change of liver elasticity in chronic hepatitis B virus infection. Chinese Journal of Evidence-Based Medicine, 2021, 21(7): 766-771. doi: 10.7507/1672-2531.202102009 Copy

  • Previous Article

    The value of three triage methodologies for critically ill patients in earthquake mass casualty

  • Next Article

    The risk factors for knee osteoarthritis among Chinese population: a meta-analysis